Study Stopped
Delays in approval process, COVID restrictions, staffing shortages
Motor Conditioning to Enhance the Effect of Physical Therapy
Exploring Brain Computer Interface Controlled Functional Electrical Stimulation as a Motor Conditioning Strategy Prior to Physical Practice in People With Subacute Spinal Cord Injury
1 other identifier
interventional
10
1 country
1
Brief Summary
Spinal Cord Injury (SCI) affects person's ability to move and feel sensation from the body. About half of patients with tetraplegia (high level SCI) have an incomplete injury, i.e. have some sensation and control of muscles preserved and could recover some function of their upper limbs. In this study the researchers would like to increase the effect of physical therapy of the upper limbs by sensory-motor priming. To achieve this they will use Brain Computer Interface (BCI) controlled Functional Electrical Stimulation (FES) immediately prior to the physical therapy of the upper limbs. BCI will be operated by motor attempt (motor priming) which will activate the FES applied to participants' hand muscles to achieve movement (sensory and motor priming). Physical therapy in this study will not replace conventional therapy that participant receive as a part of their standard treatment. There will be two groups: a treatment group (BCI FES with physical therapy) and a control group (physical therapy only), each receiving 20 therapy sessions of matched duration (40-50 min) of their dominant hand. Based on power analysis and results from our study (Osuagwu et al. 2016, J Neural Eng) there will be thirteen participants per group matched by age and the level of injury. Therapy will be applied to dominant hand only, because of the limited time available for experimental studies on participants who are already under active rehabilitation programme. Primary measures will be functional outcomes (range of movement, muscle strength, grip force, independence) while secondary outcomes will be neurological outcomes (EEG activity) and quality of life measures. The outcomes will be compared between the treatment and the control group and between the dominant and the non-dominant hand of each participant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2020
CompletedStudy Start
First participant enrolled
December 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedDecember 9, 2022
December 1, 2022
1.7 years
February 13, 2020
December 7, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Changes in Spinal Cord Independence measure (range 0 to 100, max 100)
Spinal Cord Independence measure Questionnaire regarding independence in activities of daily living
two months: baseline and upon completion of the therapy, typically 9 weeks
Change in the hand range of motion (range 0 to 90 degress, max 90 degress)
Change in the range of motion measured by goniometer (o degrees)
two months: baseline and upon completion of thetherapy, typically 9 weeks
Changes in the Manual muscle test (range 0 to 5, max 5)
Change of strength of individual hand and arm muscles
two months: baseline and upon completion of the therapy, typically 9 weeks
Change in grip strength (range 0 to 80 N, max 80 N)
Change in grip strength (N)
two months: baseline and upon completion of the therapy, typically 9 weeks
Secondary Outcomes (5)
Changes in Multichannel brain activity measured by electroencephalography (EEG) during attempted or imagined movements
two months: baseline and after completion of the therapy, typically 9 weeks
Changes in baseline multichannel electroencephalogaphy (EEG) measurement
two months: baseline and upon completion of the therapy, typically 9 weeks
Changes NASA (National Aeronautics and Space Administration) task load index
after 1st, 10st and 20th therapy session (typically 0, 3 and 9 weeks -there is a washout peiord between first and last 10 sesions)
Quebec User Evaluation of Satisfaction with Assistive Technology
Upon completion of the therapy, typically 9 weeks
Patient feedback, satisfaction with therapy
Upon completion of the therapy, typically 9 weeks
Study Arms (2)
Control
ACTIVE COMPARATORPatients receiving conventional hand therapy, time matched to the duration of total intervention in the Active group
Active
ACTIVE COMPARATORPatients receiving BCI FES prior to the conventional therapy
Interventions
Participants who decide to take part will be assigned to a treatment or a control group. Both groups will have the same assessments and the same number of therapy sessions. Therapy group will have a training that consists of Brain Computer Interface controlled Functional Electrical Stimulation followed by a physical practice of the dominant upper limb, while the control group will have a physical practice only. One experimental session will last about 60 min for both groups (including setup and therapy) and participants in each group will receive 20 sessions, about 3 times per week. The expected time needed for completion of 20 sessions is 7 weeks
Eligibility Criteria
You may qualify if:
- Upper and lower age limit as above
- Incomplete spinal cord injury at level C3-C8 or complete spinal cord injury (C3-C8) with a zone of partially preserved innervation
- Sub-acute patients, likely to remain as inpatient during the period of study
- Normal or corrected to normal vision
You may not qualify if:
- Self reported neurological conditions prior to the injury that are expected to substantially change the EEG signal (e.g. stroke, epilepsy, brain injury, Parkinson's disease)
- Inability to understand the experimental task
- Brain, brachioplexus or peripheral nerve damage occurring at the time of the spinal cord injury.
- General contraindications for using FES (implanted devices, pregnancy, sensitive skin, automatic dysreflexia)
- Halos (large neck supports surrounding head) preventing EEG recording
- Inability to sit for 1.5 hour due to skin redness or sores
- Infections and general poor health due to injury
- Unable to speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
Study Sites (1)
University of Glasgow
Glasgow, G12 8QQ, United Kingdom
Related Publications (1)
Osuagwu BC, Wallace L, Fraser M, Vuckovic A. Rehabilitation of hand in subacute tetraplegic patients based on brain computer interface and functional electrical stimulation: a randomised pilot study. J Neural Eng. 2016 Dec;13(6):065002. doi: 10.1088/1741-2560/13/6/065002. Epub 2016 Oct 14.
PMID: 27739405BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aleksandra Vuckovic, PhD
University of Glasgow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2020
First Posted
April 29, 2020
Study Start
December 9, 2020
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
December 9, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share